纖溶酶原(Plg)重組蛋白
Recombinant Plasminogen (Plg)
PL; Plasmin; Activation peptide; Angiostatin
- 編號(hào)RPB236Hu02
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來(lái)源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位分泌
- 預(yù)測(cè)分子量92.1kDa
- 實(shí)際分子量92kDa(差異分析請(qǐng)參閱說(shuō)明書(shū))
- 片段與標(biāo)簽Glu20~Asn810 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)8.2
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請(qǐng)參見(jiàn)活性蛋白。 - 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 432 ¥ 1080 ¥ 2160 ¥ 6480 ¥ 16200
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-0.125 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
NPB236Hu01 | 纖溶酶原(Plg)天然蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB236Hu03 | 纖溶酶原(Plg)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB236Hu01 | 纖溶酶原(Plg)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APB236Hu01 | 纖溶酶原(Plg)活性蛋白 | Cell?culture;?Activity?Assays. |
EPB236Hu51 | 纖溶酶原(Plg)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APB236Hu51 | 纖溶酶原(Plg)活性蛋白 | Cell?culture;?Activity?Assays. |
RPB236Hu02 | 纖溶酶原(Plg)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB236Hu07 | 纖溶酶原(Plg)多克隆抗體 | WB; IHC; ICC; IP. |
PAB236Hu01 | 纖溶酶原(Plg)多克隆抗體 | WB; IHC; ICC; IP. |
PAB236Hu05 | 纖溶酶原(Plg)多克隆抗體 | WB; IHC; ICC; IP. |
PAB236Hu02 | 纖溶酶原(Plg)多克隆抗體 | WB; IHC; ICC; IP. |
LAB236Hu81 | 纖溶酶原(Plg)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
LAB236Hu71 | 纖溶酶原(Plg)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAB236Hu24 | 纖溶酶原(Plg)單克隆抗體 | WB; IHC; ICC; IP. |
MAB236Hu25 | 纖溶酶原(Plg)單克隆抗體 | WB; IHC; ICC; IP. |
MAB236Hu26 | 纖溶酶原(Plg)單克隆抗體 | WB; IHC; ICC; IP. |
MAB236Hu22 | 纖溶酶原(Plg)單克隆抗體 | WB |
MAB236Hu21 | 纖溶酶原(Plg)單克隆抗體 | WB; IHC; ICC; IP. |
MAB236Hu23 | 纖溶酶原(Plg)單克隆抗體 | WB; IHC; ICC; IP. |
MAB236Hu27 | 纖溶酶原(Plg)單克隆抗體 | WB; IHC; ICC; IP. |
MAB236Hu29 | 纖溶酶原(Plg)單克隆抗體 | WB; IHC; ICC; IP. |
SEB236Hu | 纖溶酶原(Plg)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCB236Hu | 纖溶酶原(Plg)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LMB236Hu | 纖溶酶原(Plg)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSB236Hu01 | 纖溶酶原(Plg)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
International Journal of Molecular Sciences | The Anticoagulant Effect of PGI2S and tPA in Transgenic Umbilical Vein Endothelial Cells Is Linked to Up-Regulation of PKA and PKC [Mdpi: Source] |
J Anim Physiol Anim Nutr (Berl). | Improved milk production through PG-PL system by provision of in-house shelter management in lactating Murrah buffaloes during winter season. [pubmed:28084661] |
Neurotherapeutics | iTRAQ-Based Quantitative Proteomics Reveals the New Evidence Base for Traumatic Brain Injury Treated with Targeted Temperature Management [pubmed:29247448] |
Veterinarski?Arhiv | The influence of a modified micro-environment on stress and milk production through the plasminogen-plasmin system in Murrah buffaloes during the hot-humid?… [10.24099:vet.arhiv.170113] |
Food Bioscience | Reducing antigenicity of |?-lactoglobulin, probiotic properties and safety evaluation of Lactobacillus plantarum AHQ-14 and Lactobacillus bulgaricus BD0390 [] |
Foods | Antigenicity and Safety Evaluation of Lactiplantibacillus plantarum 7-2 Screened to Reduce α-Casein Antigen [Pubmed:35010214] |
留言咨詢